Yan Wang - Department of Pharmacy, The First College of Clinical Medical Science, China Three Gorges University & Yichang Central People’s Hospital, Yichang ۴۴۳۰۰۳, P.R. China
Yun-hui Zhang - School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou ۵۱۰۰۰۶, P.R. China
Yin-ru Tang - School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou ۵۱۰۰۰۶, P.R. China
Jie Lan - School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou ۵۱۰۰۰۶, P.R. China
Zhi-ying Huang - School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou ۵۱۰۰۰۶, P.R. China
Wei Tian - Department of Pharmacy, The First College of Clinical Medical Science, China Three Gorges University & Yichang Central People’s Hospital, Yichang ۴۴۳۰۰۳, P.R. China
Qian Huang - Department of Nephrology, The First College of Clinical Medical Science, China Three Gorges University & Yichang Central People’s Hospital, Yichang ۴۴۳۰۰۳, P.R. China
Yan Peng - Department of Pharmacy, The First College of Clinical Medical Science, China Three Gorges University & Yichang Central People’s Hospital, Yichang ۴۴۳۰۰۳, P.R. China
Yuan Gao - Department of Pharmacy, The First College of Clinical Medical Science, China Three Gorges University & Yichang Central People’s Hospital, Yichang ۴۴۳۰۰۳, P.R. China
Yue-qin Hu - Department of Pharmacy, The First College of Clinical Medical Science, China Three Gorges University & Yichang Central People’s Hospital, Yichang ۴۴۳۰۰۳, P.R. China
Xue-nong Zhang - Department of Pharmacy, The First College of Clinical Medical Science, China Three Gorges University & Yichang Central People’s Hospital, Yichang ۴۴۳۰۰۳, P.R. China

Objective(s): Cisplatin (CDDP) is a highly effective chemotherapeutic agent, but its clinical application has been limited by nephrotoxicity. Tanshinone Ⅰ (T-I), a phenanthrenequinone compound extracted from the Chinese herb Danshen, has been used to improve circulation and treat cardiovascular diseases. The aim of this study was to investigate the protective effect of T-I on CDDP-induced nephrotoxicity in mice.Materials and Methods: The BALB/c mouse models of nephrotoxicity were established by a single intraperitoneal injection of ۲۰ mg/kg CDDP on the first day of the experiment. Three hours prior to CDDP administration, the mice were dosed with ۱۰ mg/kg and ۳۰ mg/kg T-I for ۳ consecutive days intraperitoneally to explore nephroprotection of T-I.Results: Treatment with T-I significantly reduced blood urea nitrogen and creatinine levels in serum observed in CDDP-administered mice, especially at a dose of ۳۰ mg/kg. T-I at ۳۰ mg/kg significantly decreased malondialdehyde levels and increased glutathione levels and the enzymatic activity of catalase in kidney tissue compared to CDDP. Additionally, T-I (۳۰ mg/kg) significantly reversed the CDDP-decreased expression level of superoxide dismutase ۲ protein in renal tissue. Histopathological evaluation of the kidneys further confirmed the protective effect of T-I. Conclusion: The findings of this study demonstrate that T-I can protect against CDDP-induced nephrotoxicity through suppression of oxidative stress. 

Cisplatin, Mice, Nephrotoxicity, Oxidative stress, Tanshinone Ⅰ